Slide 1Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research` Rury R. Holman, MB, ChB, FRCP Professor of Diabetic Medicine Director, Diabetes Trials Unit,…
Slide 1MT For Low-Density Languages Ryan Georgi Ling 575 – MT Seminar Winter 2007 Slide 2 What is “Low Density”? Slide 3 In NLP, languages are usually chosen for: In…
Slide 1 Recruitment and Retention for Diabetes Prevention Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Roz Barber Shiprock DPP Recruitment and Retention Coordinator…
Slide 1 Recruitment and Retention for CVD Risk Reduction Carol Percy, RN, MS Shiprock DPPOS Program Coordinator Mary Hoskin, RD, MS Phoenix DPPOS Program Coordinator March…